Lazar David E.
Insider CIK 1932843 · CYCC Interim CEO, 10% owner · OPGN Chief Executive Officer, Director, 10% owner · NBY 10% owner · MINM Director, 10% owner · KALA Chief Executive Officer, Director · SOWG Chief Executive Officer, Director · ATER Chief Executive Officer, Director, 10% owner · LQR President, Director · INDP Director · QUCY Chief Executive Officer, Director, 10% owner · TTNP Chief Executive Officer, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATER Aterian, Inc. | S Sale deriv | 2026-09-25 | 2026-09-29 | 1,750,000 | $6.70 | $11.72M | 0 | SEC↗ |
| ATER Aterian, Inc. | S Sale deriv | 2026-09-25 | 2026-09-29 | 706,100 | $0.38 | $268.3K | 0 | SEC↗ |
| ATER Aterian, Inc. | S Sale deriv | 2026-09-25 | 2026-09-29 | 706,100 | $0.38 | $269.7K | 0 | SEC↗ |
| ATER Aterian, Inc. | S Sale deriv | 2026-09-25 | 2026-09-29 | 1,750,000 | $6.70 | $11.73M | 0 | SEC↗ |
| ATER Aterian, Inc. | C Conversion deriv | 2026-09-24 | 2026-09-29 | 168,900 | — | $0 | 706,100 | SEC↗ |
| ATER Aterian, Inc. | C Conversion | 2026-09-24 | 2026-09-29 | 1,300,530 | — | $0 | 8,038,030 | SEC↗ |
| ATER Aterian, Inc. | C Conversion deriv | 2026-09-24 | 2026-09-29 | 168,900 | — | $0 | 706,100 | SEC↗ |
| ATER Aterian, Inc. | C Conversion | 2026-09-24 | 2026-09-29 | 1,300,530 | — | $0 | 8,038,030 | SEC↗ |
| QUCY Quantum Cyber N.V. | C Conversion deriv | 2026-08-05 | 2026-08-07 | 124,700 | — | $0 | 875,300 | SEC↗ |
| QUCY Quantum Cyber N.V. | C Conversion deriv | 2026-08-05 | 2026-08-07 | 1,000,000 | — | $0 | 0 | SEC↗ |
| QUCY Quantum Cyber N.V. | C Conversion deriv | 2026-08-05 | 2026-08-07 | 1,000,000 | — | $0 | 0 | SEC↗ |
| QUCY Quantum Cyber N.V. | C Conversion deriv | 2026-08-05 | 2026-08-07 | 1,000,000 | — | $0 | 0 | SEC↗ |
| QUCY Quantum Cyber N.V. | C Conversion | 2026-08-05 | 2026-08-07 | 9,000,000 | $9.00 | $81.00M | 9,000,000 | SEC↗ |
| QUCY Quantum Cyber N.V. | C Conversion | 2026-08-05 | 2026-08-07 | 9,000,000 | $9.00 | $81.00M | 27,000,000 | SEC↗ |
| QUCY Quantum Cyber N.V. | C Conversion | 2026-08-05 | 2026-08-07 | 9,000,000 | $9.00 | $81.00M | 18,000,000 | SEC↗ |
| QUCY Quantum Cyber N.V. | C Conversion | 2026-08-05 | 2026-08-07 | 28,057,500 | $225.00 | $6.31B | 55,057,500 | SEC↗ |
| QUCY Quantum Cyber N.V. | C Conversion deriv | 2026-08-05 | 2026-08-07 | 124,700 | — | $0 | 875,300 | SEC↗ |
| QUCY Quantum Cyber N.V. | C Conversion deriv | 2026-08-05 | 2026-08-07 | 1,000,000 | — | $0 | 0 | SEC↗ |
| QUCY Quantum Cyber N.V. | C Conversion deriv | 2026-08-05 | 2026-08-07 | 1,000,000 | — | $0 | 0 | SEC↗ |
| QUCY Quantum Cyber N.V. | C Conversion deriv | 2026-08-05 | 2026-08-07 | 1,000,000 | — | $0 | 0 | SEC↗ |
| QUCY Quantum Cyber N.V. | C Conversion | 2026-08-05 | 2026-08-07 | 28,057,500 | $225.00 | $6.31B | 55,057,500 | SEC↗ |
| QUCY Quantum Cyber N.V. | C Conversion | 2026-08-05 | 2026-08-07 | 9,000,000 | $9.00 | $81.00M | 27,000,000 | SEC↗ |
| QUCY Quantum Cyber N.V. | C Conversion | 2026-08-05 | 2026-08-07 | 9,000,000 | $9.00 | $81.00M | 18,000,000 | SEC↗ |
| QUCY Quantum Cyber N.V. | C Conversion | 2026-08-05 | 2026-08-07 | 9,000,000 | $9.00 | $81.00M | 9,000,000 | SEC↗ |
| ATER Aterian, Inc. | C Conversion deriv | 2026-08-04 | 2026-09-11 | 875,000 | — | $0 | 6,737,500 | SEC↗ |
| ATER Aterian, Inc. | C Conversion | 2026-08-04 | 2026-09-11 | 875,000 | $2.00 | $1.75M | 6,737,500 | SEC↗ |
| ATER Aterian, Inc. | C Conversion deriv | 2026-08-04 | 2026-09-11 | 875,000 | — | $0 | 6,737,500 | SEC↗ |
| ATER Aterian, Inc. | C Conversion | 2026-08-04 | 2026-09-11 | 875,000 | $2.00 | $1.75M | 6,737,500 | SEC↗ |
| ATER Aterian, Inc. | A Award deriv | 2026-07-17 | 2026-09-11 | 1,750,000 | $2.00 | $3.50M | 1,750,000 | SEC↗ |
| ATER Aterian, Inc. | A Award deriv | 2026-07-17 | 2026-09-11 | 1,750,000 | $2.00 | $3.50M | 1,750,000 | SEC↗ |
| ATER Aterian, Inc. | A Award deriv | 2026-04-27 | 2026-05-01 | 1,750,000 | — | $0 | 1,750,000 | SEC↗ |
| MYNZ Quantum Cyber N.V. | A Award deriv | 2026-04-22 | 2026-04-28 | 1,000,000 | $1.50 | $1.50M | 1,000,000 | SEC↗ |
| MYNZ Quantum Cyber N.V. | A Award deriv | 2026-04-22 | 2026-04-28 | 1,000,000 | $1.50 | $1.50M | 1,000,000 | SEC↗ |
| SOWG Sow Good Inc. | A Award | 2026-03-31 | 2026-04-02 | 5,740,000 | $0.14 | $803.6K | 5,740,000 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | S Sale deriv | 2026-03-23 | 2026-03-24 | 700,000 | — | $0 | 0 | SEC↗ |
| INDP Indaptus Therapeutics, Inc | S Sale deriv | 2026-03-23 | 2026-03-24 | 196,800 | — | $0 | 103,200 | SEC↗ |
| MYNZ MAINZ BIOMED N.V. | A Award deriv | 2026-02-13 | 2026-03-03 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| MYNZ MAINZ BIOMED N.V. | A Award deriv | 2026-02-13 | 2026-03-03 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| MYNZ MAINZ BIOMED N.V. | A Award deriv | 2026-02-13 | 2026-03-03 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| SOWG Sow Good Inc. | M Exercise deriv | 2025-12-31 | 2026-04-02 | 410,000 | $2.00 | $820.0K | 1,090,000 | SEC↗ |
| SOWG Sow Good Inc. | A Award deriv | 2025-12-31 | 2026-01-05 | 1,500,000 | $2.00 | $3.00M | 1,500,000 | SEC↗ |
| KALA KALA BIO, Inc. | J Other deriv | 2025-12-18 | 2025-12-22 | 368,614 | — | $0 | 0 | SEC↗ |
| KALA KALA BIO, Inc. | A Award deriv | 2025-11-24 | 2025-11-26 | 900,000 | — | $0 | 900,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | M Exercise deriv | 2025-10-21 | 2026-01-29 | 39,925 | — | $0 | 0 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award | 2025-10-21 | 2026-01-29 | 6,388,000 | — | $0 | 6,388,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | S Sale deriv | 2025-10-16 | 2025-10-17 | 441,325 | — | $0 | 39,925 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | S Sale | 2025-07-30 | 2025-08-04 | 6,750 | $12.36 | $83.4K | 155,838 | SEC↗ |
| LQR LQR House Inc. | A Award | 2025-04-02 | 2025-04-07 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | M Exercise deriv | 2025-02-26 | 2025-02-28 | 1,745,262 | — | $0 | 354,738 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | M Exercise deriv | 2025-02-26 | 2025-02-28 | 1,000,000 | — | $0 | 0 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | M Exercise | 2025-02-26 | 2025-02-28 | 191,978,820 | — | $0 | 194,628,820 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | M Exercise | 2025-02-26 | 2025-02-28 | 2,650,000 | — | $0 | 2,650,000 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | S Sale | 2025-02-26 | 2025-02-28 | 194,628,820 | $0.03 | $5.84M | 0 | SEC↗ |
| MINM FiEE, Inc. | S Sale deriv | 2025-02-18 | 2025-03-10 | 2,800,000 | — | $0 | 0 | SEC↗ |
| MINM FiEE, Inc. | S Sale deriv | 2025-02-18 | 2025-03-10 | 2,219,447 | — | $0 | 85,910 | SEC↗ |
| MINM FiEE, Inc. | A Award | 2025-02-18 | 2025-03-10 | 1,200,000 | — | $0 | 2,681,980 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2025-02-06 | 2025-02-10 | 2,100,000 | — | $0 | 2,100,000 | SEC↗ |
| MINM MINIM, INC. | P Buy | 2024-12-26 | 2024-12-31 | 1,456,980 | $0.03 | $43.7K | 1,481,980 | SEC↗ |
| LQR LQR House Inc. | S Sale | 2024-11-25 | 2024-11-25 | 280,000 | — | $0 | 0 | SEC↗ |
| LQR LQR House Inc. | S Sale | 2024-11-21 | 2024-11-25 | 821,818 | — | $0 | 280,000 | SEC↗ |
| MINM MINIM, INC. | A Award deriv | 2024-10-21 | 2024-10-22 | 305,357 | — | $0 | 2,305,357 | SEC↗ |
| OPGN OPGEN INC | S Sale deriv | 2024-07-30 | 2024-08-01 | 550,000 | — | $0 | 0 | SEC↗ |
| OPGN OPGEN INC | A Award deriv | 2024-04-23 | 2024-08-01 | 150,000 | $1.00 | $150.0K | 550,000 | SEC↗ |
| OPGN OPGEN INC | P Buy deriv | 2024-04-23 | 2024-04-25 | 150,000 | $1.00 | $150.0K | 550,000 | SEC↗ |
| OPGN OPGEN INC | A Award | 2024-04-11 | 2024-04-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| OPGN OPGEN INC | A Award deriv | 2024-04-05 | 2024-07-31 | 200,000 | $1.00 | $200.0K | 200,000 | SEC↗ |
| OPGN OPGEN INC | P Buy deriv | 2024-04-05 | 2024-04-08 | 200,000 | $1.00 | $200.0K | 9,600,000 | SEC↗ |
| MINM MINIM, INC. | P Buy deriv | 2024-01-29 | 2024-01-31 | 2,000,000 | $1.40 | $2.80M | 2,000,000 | SEC↗ |
| MINM MINIM, INC. | P Buy deriv | 2024-01-29 | 2024-01-31 | 2,800,000 | — | $0 | 2,800,000 | SEC↗ |
| MINM MINIM, INC. | A Award | 2024-01-22 | 2024-01-24 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | A Award | 2023-07-26 | 2023-07-31 | 100,000 | — | $0 | 100,000 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | S Sale | 2023-06-21 | 2023-06-23 | 359,066 | $1.23 | $441.7K | 0 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | S Sale | 2023-06-21 | 2023-06-23 | 3,388,902 | $1.23 | $4.17M | 0 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | S Sale | 2023-06-21 | 2023-06-28 | 3,388,902 | $1.23 | $4.17M | 0 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | S Sale | 2023-06-21 | 2023-06-28 | 359,066 | $1.23 | $441.7K | 0 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | P Buy | 2023-01-25 | 2023-01-26 | 20,000 | $1.00 | $20.0K | 3,388,902 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | P Buy | 2023-01-24 | 2023-01-26 | 37,500 | $0.97 | $36.4K | 3,368,902 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | P Buy | 2022-07-07 | 2022-07-08 | 744,294 | $0.99 | $736.9K | 3,331,402 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | P Buy | 2022-07-06 | 2022-07-08 | 1,165,975 | $0.77 | $897.8K | 2,587,108 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | P Buy | 2022-07-06 | 2022-07-08 | 315,921 | $0.89 | $281.2K | 359,066 | SEC↗ |